# Long-term Prednisone Use for End-stage Heart Failure

> **NCT02282683** · PHASE2,PHASE3 · UNKNOWN · sponsor: **Hebei Medical University** · enrollment: 90 (estimated)

## Conditions studied

- Heart Failure
- Hyperuricemia

## Interventions

- **DRUG:** prednisone

## Key facts

- **NCT ID:** NCT02282683
- **Lead sponsor:** Hebei Medical University
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2013-12
- **Primary completion:** 2017-12
- **Final completion:** 2017-12
- **Target enrollment:** 90 (ESTIMATED)
- **Last updated:** 2017-01-12


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02282683

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02282683, "Long-term Prednisone Use for End-stage Heart Failure". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT02282683. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*